Augmenting research consent: should large language models (LLMs) be used for informed consent to clinical research?
Research Ethics · 2025-10 · 21 (4) · 644-670
DOI: 10.1177/17470161241298726 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Ethics, online erschienen am 08.12.2024. Verfasst von Jemima W Allen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Monash University, Australia; University of Oxford, UK. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
The integration of artificial intelligence (AI), particularly large language models (LLMs) like OpenAI’s ChatGPT, into clinical research could significantly enhance the informed consent process. This paper critically examines the ethical implications of employing LLMs to facilitate consent in clinical research. LLMs could offer considerable benefits, such as improving participant understanding and engagement, broadening participants’ access to the relevant information for informed consent and increasing the efficiency of consent procedures. However, these theoretical advantages are accompanied by ethical risks, including the potential for misinformation, coercion and challenges in accountability. Given the complex nature of consent in clinical research, which involves both written documentation (in the form of participant information sheets and informed consent forms) and in-person conversations with a researcher, the use of LLMs raises significant concerns about the adequacy of existing regulatory frameworks. Institutional Review Boards (IRBs) will need to consider substantial reforms to accommodate the integration of LLM-based consent processes. We explore five potential models for LLM implementation, ranging from supplementary roles to complete replacements of current consent processes, and offer recommendations for researchers and IRBs to navigate the ethical landscape. Thus, we aim to provide practical recommendations to facilitate the ethical introduction of LLM-based consent in research settings by considering factors such as participant understanding, information accuracy, human oversight and types of LLM applications in clinical research consent.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Monash University, Australia; University of Oxford, UK.
- National University of Singapore, Singapore.
- University of Copenhagen, Denmark; University of Oxford, UK.
- University of Oxford, UK; National University of Singapore, Singapore.
- National University of Singapore, Singapore; Monash University, Australia; Oxford University Hospitals NHS Foundation Trust, UK; Murdoch Children's Research Institute, Australia.
ORCID-Profile: Jemima W Allen
Förderung
- Wellcome Trust
Zitieren
APA
Allen, J. W., Schaefer, O., Mann, S. P., Earp, B. D., & Wilkinson, D. (2025). Augmenting research consent: should large language models (LLMs) be used for informed consent to clinical research?. Research Ethics, 21(4), 644-670. https://doi.org/10.1177/17470161241298726
Vancouver
Allen JW, Schaefer O, Mann SP, Earp BD, Wilkinson D. Augmenting research consent: should large language models (LLMs) be used for informed consent to clinical research?. Research Ethics. 2025;21(4):644-670. doi:10.1177/17470161241298726
BibTeX
@article{Allen2025,
author = {Allen, Jemima W and Schaefer, Owen and Mann, Sebastian Porsdam and Earp, Brian D and Wilkinson, Dominic},
title = {Augmenting research consent: should large language models (LLMs) be used for informed consent to clinical research?},
journal = {Research Ethics},
year = {2025},
volume = {21},
number = {4},
pages = {644--670},
doi = {10.1177/17470161241298726}
}
EUVIMED